Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)
HKD 11.12
(0.18%)
HKD 11.12
(0.18%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -156.52 Million CNY | 29.55% |
| 2022 | -222.18 Million CNY | -1.89% |
| 2021 | -218.05 Million CNY | -123.0% |
| 2020 | -97.78 Million CNY | -41.83% |
| 2019 | -68.94 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 18.29 Million CNY | 0.0% |
| 2024 Q1 | 18.29 Million CNY | 144.42% |
| 2023 FY | -156.52 Million CNY | 29.55% |
| 2023 Q2 | -41.06 Million CNY | 0.0% |
| 2023 Q4 | -41.19 Million CNY | -26.7% |
| 2023 Q1 | -41.06 Million CNY | 43.72% |
| 2023 Q3 | -32.51 Million CNY | 20.83% |
| 2022 Q2 | -38.79 Million CNY | 0.0% |
| 2022 FY | -222.18 Million CNY | -1.89% |
| 2022 Q3 | -72.96 Million CNY | -88.08% |
| 2022 Q1 | -38.79 Million CNY | 45.31% |
| 2022 Q4 | -72.96 Million CNY | 0.0% |
| 2021 Q3 | -70.92 Million CNY | -85.89% |
| 2021 Q2 | -38.15 Million CNY | 0.0% |
| 2021 FY | -218.05 Million CNY | -123.0% |
| 2021 Q4 | -70.92 Million CNY | 0.0% |
| 2021 Q1 | -38.15 Million CNY | -23.09% |
| 2020 FY | -97.78 Million CNY | -41.83% |
| 2020 Q3 | -30.99 Million CNY | -75.4% |
| 2020 Q1 | -17.67 Million CNY | 0.0% |
| 2020 Q2 | -17.67 Million CNY | 0.0% |
| 2020 Q4 | -30.99 Million CNY | 0.0% |
| 2019 FY | -68.94 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Vincent Medical Holdings Limited | 65.78 Million HKD | 337.949% |